Company · CIK 1822711

# PARDES BIOSCIENCES, INC.

| CIK | [1822711](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001822711) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-05-17 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-262279 | Registered company Effective | 2022-01-21 | 2023-08-31 | 6 |
| 333-269192 | Shelf Effective | 2023-01-12 | 2023-08-31 | 3 |
| 333-252435 | IPO Final prospectus | 2021-01-26 | 2021-02-18 | 4 |

## Filings

 15

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2023-08-31 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1822711/999999999523002542/9999999995-23-002542-index.htm) Declared effective | 333-269192 | 9999999995-23-002542 |
| 2023-08-31 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1822711/999999999523002540/9999999995-23-002540-index.htm) Declared effective | 333-262279 | 9999999995-23-002540 |
| 2023-01-20 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1822711/999999999523000151/9999999995-23-000151-index.htm) Declared effective | 333-269192 | 9999999995-23-000151 |
| 2023-01-17 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1822711/999999999523000115/9999999995-23-000115-index.htm) Declared effective | 333-262279 | 9999999995-23-000115 |
| 2023-01-12 | [S-3](https://www.sec.gov/Archives/edgar/data/1822711/000119312523006752/0001193125-23-006752-index.htm) Shelf registered | 333-269192 | 0001193125-23-006752 |
| 2022-03-31 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1822711/999999999522000793/9999999995-22-000793-index.htm) Declared effective | 333-262279 | 9999999995-22-000793 |
| 2022-02-01 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1822711/999999999522000296/9999999995-22-000296-index.htm) Declared effective | 333-262279 | 9999999995-22-000296 |
| 2022-01-28 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1822711/000119312522021684/0001193125-22-021684-index.htm) Amendment | 333-262279 | 0001193125-22-021684 |
| 2022-01-21 | [S-1](https://www.sec.gov/Archives/edgar/data/1822711/000119312522014843/0001193125-22-014843-index.htm) Registration filed | 333-262279 | 0001193125-22-014843 |
| 2021-12-01 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1822711/999999999521004523/9999999995-21-004523-index.htm) Declared effective | 333-258442 | 9999999995-21-004523 |
| 2021-02-18 | [424B4](https://www.sec.gov/Archives/edgar/data/1822711/000121390021010337/0001213900-21-010337-index.htm) Final prospectus | 333-252435 | 0001213900-21-010337 |
| 2021-02-16 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1822711/999999999521000655/9999999995-21-000655-index.htm) Declared effective | 333-252435 | 9999999995-21-000655 |
| 2021-02-09 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1822711/000121390021007715/0001213900-21-007715-index.htm) Amendment | 333-252435 | 0001213900-21-007715 |
| 2021-01-26 | [S-1](https://www.sec.gov/Archives/edgar/data/1822711/000121390021004399/0001213900-21-004399-index.htm) Registration filed | 333-252435 | 0001213900-21-004399 |
| 2020-09-02 | [DRS](https://www.sec.gov/Archives/edgar/data/1822711/000121390020025064/0001213900-20-025064-index.htm) Draft made public | 377-03491 | 0001213900-20-025064 |

[All filings of this company](https://equitycapital.markets/filings?cik=1822711) · [CSV](https://equitycapital.markets/filings.csv?cik=1822711)

---
Source page: https://equitycapital.markets/company/1822711 · Data: U.S. SEC EDGAR · CC BY 4.0